Cipla – Negative; Partner Unit Gets Import Alert
Cipla’s partner unit - Pharmathen's Rodopi - as per FDA's website is under import alert
Cipla has partnership with Pharmathen International S.A. - specifically its Rodopi, Greece facility
This unit manufactures Lanreotide Injection
This means Lanreotide Injection revenue goes out of estimates
Analyst expected $50-60 million revenue in FY27 and $100 million in FY28 from Lanreotide Injection
#Cipla#USFDA#ImportAlert
🚢 Thinking of importing from China?
Don’t miss our eye-opening awareness video for Indian importers!
Learn what others won’t tell you 👀
#ImportAlert#WintrackInc#ChinaTrade
Holy guacamole - It's #NationalAvocadoDay! 🥑 Did you know that J.O. Alvarez, Inc. has over 65 years of #FDA experience? We specialize in having your products removed from FDA #ImportAlert.
Contact us today for more information at info@joalvarez.com
Before you buy imported #DietarySupplements online, beware. Many imported weight loss products contain hidden/dangerous Rx drug ingredients. The FDA keeps these harmful products off the market by issuing an #ImportAlert. LEARN MORE about import alerts: go.usa.gov/xABCw
ALT Photo of woman is looking at instructions for medicine on Internet